0001209191-17-029297.txt : 20170502 0001209191-17-029297.hdr.sgml : 20170502 20170502173928 ACCESSION NUMBER: 0001209191-17-029297 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170428 FILED AS OF DATE: 20170502 DATE AS OF CHANGE: 20170502 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: 1801 AUGUSTINE CUT-OFF CITY: WILMINGTON STATE: DE ZIP: 19803 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRYSKA DAVID W CENTRAL INDEX KEY: 0001202335 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 17806381 MAIL ADDRESS: STREET 1: 749 N MARY AVE CITY: SUNNYVALE STATE: CA ZIP: 94085 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-28 0 0000879169 INCYTE CORP INCY 0001202335 GRYSKA DAVID W 1801 AUGUSTINE CUT-OFF WILMINGTON DE 19803 0 1 0 0 Executive Vice President, CFO Common Stock 2017-04-28 4 M 0 1389 67.06 A 20404 D Common Stock 2017-04-28 4 S 0 1389 124.26 D 19015 D Non-Qualified Stock Option (right to buy) 67.06 2017-04-28 4 M 0 1389 0.00 D 2021-10-30 Common Stock 1389 9725 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person. This includes an aggregate of 11,187 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. Beginning October 31, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years. /s/ David W. Gryska 2017-05-02